Rania Jalal has more than 20 years of experience in Pharmaceutical Development Chemistry Manufacturing and Controls (CMC). Rania has worked at small, mid, and large pharmaceutical and biotech companies on a variety of dosage forms from early proof of concept (Phase 1) to commercial readiness.

Prior to joining Halloran, Rania was a self-employed at RJ Pharma Consulting, LLC. Rania focused on providing technical and strategic CMC expertise in drug product development and manufacturing processes, as well as CMC strategic planning of regulatory submissions. This included performing gap analysis for the CMC package, pre-IND and End of Phase (EOP2) Agency meeting requests and briefing document preparation, as well as preparation of CMC modules for a variety of regulatory submissions (IND, NDA, 505 b(2), ANDA, BLA, CTA and IMPD).

Education:
University of Manchester, Ph.D in Pharmaceutics
Applied Science University, Bachelor of Science in Pharmacy
University of St. Thomas, Project Management Certificate